FDA Approves First Non-Antipsychotic Drug for Alzheimer's Agitation
Summary
Oral NMDA receptor antagonist gets an expanded indication
Original reporting
Open original sourceAFBytes is a read-only aggregator. Use the original source for full context and complete reporting.